Compile Data Set for Download or QSAR
Found 91 with Last Name = 'thomas' and Initial = 'ps'
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395262(CHEMBL2163999)copy SMILEScopy InChI
Affinity DataKi:  6.00E+3nMAssay Description:Competitive inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP by Lineweaver-Burke plot analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395284(CHEMBL2163996)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395283(CHEMBL2163995)copy SMILEScopy InChI
Affinity DataIC50: 3.40nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395285(CHEMBL2163997)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395272(CHEMBL1231206)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Binding affinity to recombinant MAPKAP-K2 using KKKALSRQLSVAA as substrate after 4 mins by surface plasmon resonance spectroscopic analysisMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395267(CHEMBL2163608)copy SMILEScopy InChI
Affinity DataIC50: 54nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395262(CHEMBL2163999)copy SMILEScopy InChI
Affinity DataIC50: 55nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395269(CHEMBL2163610)copy SMILEScopy InChI
Affinity DataIC50: 57nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395268(CHEMBL2163611)copy SMILEScopy InChI
Affinity DataIC50: 76nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395275(CHEMBL2163616)copy SMILEScopy InChI
Affinity DataIC50: 130nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395274(CHEMBL1235213)copy SMILEScopy InChI
Affinity DataIC50: 130nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50225787(2,4-diamino-6,7-dihydroxy-10H-9-oxa-1-aza-anthrace...)copy SMILEScopy InChI
Affinity DataIC50: 130nMAssay Description:Inhibition of MAPKAP-K2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395270(CHEMBL2163609)copy SMILEScopy InChI
Affinity DataIC50: 140nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395271(CHEMBL2163612)copy SMILEScopy InChI
Affinity DataIC50: 160nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395266(CHEMBL2163607)copy SMILEScopy InChI
Affinity DataIC50: 200nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395303(CHEMBL2163981)copy SMILEScopy InChI
Affinity DataIC50: 360nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395266(CHEMBL2163607)copy SMILEScopy InChI
Affinity DataIC50: 390nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395282(CHEMBL2163994)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50059889((staurosporine)3-methoxy-2-methyl-4-methylamino-(2...)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395281(CHEMBL2163993)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395278(CHEMBL2163984)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395263(CHEMBL2163604)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395277(CHEMBL2163624)copy SMILEScopy InChI
Affinity DataIC50: 510nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395295(CHEMBL2163625)copy SMILEScopy InChI
Affinity DataIC50: 570nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395280(CHEMBL2163992)copy SMILEScopy InChI
Affinity DataIC50: 600nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395278(CHEMBL2163984)copy SMILEScopy InChI
Affinity DataIC50: 700nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395276(CHEMBL2163623)copy SMILEScopy InChI
Affinity DataIC50: 700nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395290(CHEMBL2163618)copy SMILEScopy InChI
Affinity DataIC50: 700nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395289(CHEMBL2163617)copy SMILEScopy InChI
Affinity DataIC50: 700nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395263(CHEMBL2163604)copy SMILEScopy InChI
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395262(CHEMBL2163999)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395288(CHEMBL2163613)copy SMILEScopy InChI
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395264(CHEMBL2163605)copy SMILEScopy InChI
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395279(CHEMBL2163991)copy SMILEScopy InChI
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395265(CHEMBL2163606)copy SMILEScopy InChI
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetSerine/threonine-protein kinase Chk2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395274(CHEMBL1235213)copy SMILEScopy InChI
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of human CHK2 by radiometric assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395287(CHEMBL2163614)copy SMILEScopy InChI
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395310(CHEMBL2163989)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395280(CHEMBL2163992)copy SMILEScopy InChI
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395301(CHEMBL2163979)copy SMILEScopy InChI
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395286(CHEMBL2163615)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395285(CHEMBL2163997)copy SMILEScopy InChI
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395281(CHEMBL2163993)copy SMILEScopy InChI
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395299(CHEMBL2163353)copy SMILEScopy InChI
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395262(CHEMBL2163999)copy SMILEScopy InChI
Affinity DataIC50: 4.90E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Mus musculus)
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395274(CHEMBL1235213)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MAPKAP-K2 in mouse whole blood assessed as inhibition of LPS-induced TNFalpha production by ELISAMore data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395279(CHEMBL2163991)copy SMILEScopy InChI
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395265(CHEMBL2163606)copy SMILEScopy InChI
Affinity DataIC50: 6.40E+3nMAssay Description:Inhibition of CDK2 after 60 mins using [33P]-gamma-ATP by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395291(CHEMBL2163619)copy SMILEScopy InChI
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibition of MAPKAP-K2 using KKLNRTLSVA as substrate and [33P]-gamma-ATP after 30 mins by liquid scintillation counterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20K29PXPubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Teijin Pharma Ltd.

Curated by ChEMBL
LigandPNGBDBM50395274(CHEMBL1235213)copy SMILEScopy InChI
Affinity DataIC50: 7.20E+3nMAssay Description:Inhibition of human MAPKAP-K2 in THP1 cells assessed as inhibition of LPS-induced TNFalpha production incubated 1 hr prior to LPS challenge measured ...More data for this Ligand-Target Pair
Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: